1
Total investments
0
Early stage
0
Mid stage
0
Late stage
4y
Years active
Portfolio
0 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
No investments found
Experience · 2 entries
All (2)
Investments (1)
2022
K
Investor/Advisor
Jan 2022
Kyto Technology and Life Science, Inc., formerly Kyto Biopharma, Inc., seeks to develop a specialized vehicle for early stage technology and life science companies. The Company operates as a mentor, advisor, external manager and investor for selected privately held companies in the United States of America, Canada and Israel. The Companys portfolio includes CNote Group, Inc. (CNote), Exodos/Achelios Therapeutics, Inc. (Achelios), Seal Rock Therapeutics, Inc., and Crater, LLC (Crater). CNote provides an alternative savings product that pays up to 35x the interest of a traditional savings account. Crater provides the SurveyBot software program, which enables video chat between a moving companys representative and the customer. Achelios is a specialty pharmaceutical company with primary focus on new therapeutic entity (NTE) development for the treatment of pain and inflammation by delivered medications.
2018
Senior Director
2018
Accordion is a financial consulting firm uniquely focused on private equity. Rooted in data and technology, Accordion’s expertise lives at the intersection of sponsors and PE-backed CFOs. Our team helps drive value creation for clients, with services supporting the Office of the CFO across all stages of the investment lifecycle—including foundational accounting, strategic financial planning and analysis enhancement, CFO-led performance, transaction support, and turnaround and restructuring solutions. All of Accordion’s services are powered by deep expertise in data and analytics, CFO-specific technology, and finance-led transformations. Accordion is headquartered in New York with ten offices around the globe.